FAS and neoplasm: In the RLS40 model, the neutrophil phenotype was associated with the tumor growth rate, where, in aggressively progressed tumors (RLS40High), CCL17 was expressed, while, in mice with controlled tumor growth (RLS40Low), anti-tumor markers were expressed (FAS, ICAM-1, PD-L1).